Financials
Financial year 2025
Elpers Farma from Dilbeek, company number BE0538703158, closed financial year 2025 with a result of € 272,796 after tax. For that financial year Elpers Farma recorded a gross margin of € 243,046 and equity of € 1.7 million. Compared with financial year 2024, the result moved from € 169,609 to € 272,796. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 14, 2026.
€ 1.7 million
▲ 20% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 272,796
▲ 61% vs 2024
Profit after tax over the fiscal year.
€ 52,908
▼ 43% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1.6 million.
People and assets in 2025
€ 1,431
▼ 49% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 521,016
▼ 20% vs 2024
€ 132,903 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 17,422
▲ 11% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 243,047 | € 244,207 | € 238,952 | € 243,046 | ▲ 2% |
| Profit after taxes | € 216,985 | € 270,621 | € 169,609 | € 272,796 | ▲ 61% |
| Equity | € 1,093,175 | € 1,333,795 | € 1,378,405 | € 1,651,201 | ▲ 20% |
| Total debts | € 1,085,383 | € 854,531 | € 829,559 | € 550,785 | ▼ 34% |
| Cash | € 39,467 | € 38,361 | € 93,049 | € 52,908 | ▼ 43% |
| Retained profit | € 1,074,575 | € 1,315,195 | € 1,359,805 | € 1,632,601 | ▲ 20% |
| Dividend | € 147,000 | € 30,000 | € 125,000 | € 0 | ▼ 100% |
| Bank debt | € 899,634 | € 775,972 | € 649,750 | € 521,016 | ▼ 20% |
| Balance sheet total | € 2,178,557 | € 2,188,326 | € 2,207,963 | € 2,201,987 |
Key figures of Elpers Farma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Elpers Farma?
What happened at Elpers Farma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 272,796 (▲ 61% vs 2024). filed late Source: NBB ↗
- New establishment in Dilbeek. KBO
- Thomas Elpers became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 216,985 profit in 2022 to € 272,796 profit in 2025.
Paid € 205,283 in corporate taxes since 2022.
Best year ever: 2025, with € 272,796 profit.
Paid out € 302,000 in dividends to the owners in total.
Management
Behind Elpers Farma is Thomas Elpers. It owns 98.7% of Fardil and 25% of Pharma4Future itself.
Directors
According to the 2025 annual accounts
Thomas Elpers
Director
since 2013
Establishments
Establishment units
Physical locations of this company
Stationsstraat 253
1700 Dilbeek
Lennikseweg 17
1700 Dilbeek
Active since 1 October 2013
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0538.703.158
- VAT number
- BE 0538.703.158
- Registered office
- Stationsstraat 253, 1700 Dilbeek
- Names & denominations
- Elpers Farma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 September 2013
- Peppol
- Active · Active since 25 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten